Matches in SemOpenAlex for { <https://semopenalex.org/work/W2025707250> ?p ?o ?g. }
- W2025707250 endingPage "1053" @default.
- W2025707250 startingPage "1047" @default.
- W2025707250 abstract "Bisphosphonates are effective in the prevention and treatment of bone disease in multiple myeloma (MM). Osteonecrosis of the jaw is Increasingly recognized as a serious complication of long-term bisphosphonate therapy. Issues such as the choice of bisphosphonate and duration of therapy have become the subject of intense debate given patient safety concerns. We reviewed available data concerning the use of bisphosphonates in MM. Guidelines for the use of bisphosphonates in MM were developed by a multidisciplinary panel consisting of hematologists, dental specialists, and nurses specializing in the treatment of MM. We conclude that intravenous pamidronate and intravenous zoledronic acid are equally effective and superior to placebo in reducing skeletal complications. Pamidronate is favored over zoledronic acid until more data are available on the risk of complications (osteonecrosis of the jaw). We recommend discontinuing bisphosphonates after 2 years of therapy for patients who achieve complete response and/or plateau phase. For patients whose disease is active, who have not achieved a response, or who have threatening bone disease beyond 2 years, therapy can be decreased to every 3 months. These guidelines were developed in the Interest of patient safety and will be reexamined as new data emerge regarding risks and benefits." @default.
- W2025707250 created "2016-06-24" @default.
- W2025707250 creator A5000308170 @default.
- W2025707250 creator A5001453763 @default.
- W2025707250 creator A5003015868 @default.
- W2025707250 creator A5004152557 @default.
- W2025707250 creator A5007747233 @default.
- W2025707250 creator A5012884078 @default.
- W2025707250 creator A5015553497 @default.
- W2025707250 creator A5018475678 @default.
- W2025707250 creator A5019568320 @default.
- W2025707250 creator A5020125149 @default.
- W2025707250 creator A5023193953 @default.
- W2025707250 creator A5026574827 @default.
- W2025707250 creator A5027394636 @default.
- W2025707250 creator A5035999874 @default.
- W2025707250 creator A5036150860 @default.
- W2025707250 creator A5038127092 @default.
- W2025707250 creator A5051470930 @default.
- W2025707250 creator A5052346975 @default.
- W2025707250 creator A5056089649 @default.
- W2025707250 creator A5066940168 @default.
- W2025707250 creator A5072775789 @default.
- W2025707250 creator A5076611748 @default.
- W2025707250 creator A5083065759 @default.
- W2025707250 creator A5091287816 @default.
- W2025707250 date "2006-08-01" @default.
- W2025707250 modified "2023-10-10" @default.
- W2025707250 title "Mayo Clinic Consensus Statement for the Use of Bisphosphonates in Multiple Myeloma" @default.
- W2025707250 cites W1497973518 @default.
- W2025707250 cites W1530002712 @default.
- W2025707250 cites W1532955823 @default.
- W2025707250 cites W1970446209 @default.
- W2025707250 cites W1971844177 @default.
- W2025707250 cites W1974568982 @default.
- W2025707250 cites W1982258033 @default.
- W2025707250 cites W1989134488 @default.
- W2025707250 cites W1990119475 @default.
- W2025707250 cites W1990811870 @default.
- W2025707250 cites W1995093156 @default.
- W2025707250 cites W1995238317 @default.
- W2025707250 cites W1996898338 @default.
- W2025707250 cites W2000096438 @default.
- W2025707250 cites W2003204537 @default.
- W2025707250 cites W2011082590 @default.
- W2025707250 cites W201366182 @default.
- W2025707250 cites W2024352236 @default.
- W2025707250 cites W2057789905 @default.
- W2025707250 cites W2066185907 @default.
- W2025707250 cites W2076157012 @default.
- W2025707250 cites W2103883579 @default.
- W2025707250 cites W2107208293 @default.
- W2025707250 cites W2115679939 @default.
- W2025707250 cites W2125636044 @default.
- W2025707250 cites W2126347015 @default.
- W2025707250 cites W2131217979 @default.
- W2025707250 cites W2134828568 @default.
- W2025707250 cites W2137302084 @default.
- W2025707250 cites W2141521877 @default.
- W2025707250 cites W2141884093 @default.
- W2025707250 cites W2144860907 @default.
- W2025707250 cites W2146143139 @default.
- W2025707250 cites W2148188974 @default.
- W2025707250 cites W2154102227 @default.
- W2025707250 cites W2156376066 @default.
- W2025707250 cites W2158787920 @default.
- W2025707250 cites W2162243202 @default.
- W2025707250 cites W2163852287 @default.
- W2025707250 cites W2166925007 @default.
- W2025707250 cites W2166970835 @default.
- W2025707250 cites W2167130416 @default.
- W2025707250 cites W2168929741 @default.
- W2025707250 cites W2169512870 @default.
- W2025707250 cites W2180645505 @default.
- W2025707250 cites W2325302070 @default.
- W2025707250 cites W2474873081 @default.
- W2025707250 cites W2492496307 @default.
- W2025707250 cites W282464114 @default.
- W2025707250 cites W32740176 @default.
- W2025707250 cites W4239940712 @default.
- W2025707250 doi "https://doi.org/10.4065/81.8.1047" @default.
- W2025707250 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16901028" @default.
- W2025707250 hasPublicationYear "2006" @default.
- W2025707250 type Work @default.
- W2025707250 sameAs 2025707250 @default.
- W2025707250 citedByCount "220" @default.
- W2025707250 countsByYear W20257072502012 @default.
- W2025707250 countsByYear W20257072502013 @default.
- W2025707250 countsByYear W20257072502014 @default.
- W2025707250 countsByYear W20257072502015 @default.
- W2025707250 countsByYear W20257072502016 @default.
- W2025707250 countsByYear W20257072502017 @default.
- W2025707250 countsByYear W20257072502019 @default.
- W2025707250 countsByYear W20257072502020 @default.
- W2025707250 countsByYear W20257072502021 @default.
- W2025707250 countsByYear W20257072502022 @default.
- W2025707250 countsByYear W20257072502023 @default.
- W2025707250 crossrefType "journal-article" @default.